Compounds > n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine
Page last updated: 2024-09-03

n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine and niraparib

n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine has been researched along with niraparib in 1 studies

Compound Research Comparison

Studies
(n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine)		Trials
(n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine)		Recent Studies (post-2010)
(n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine)		Studies
(niraparib)		Trials
(niraparib)		Recent Studies (post-2010) (niraparib)
7911621246209

Protein Interaction Comparison

ProteinTaxonomyn-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine (IC50)niraparib (IC50)
Poly [ADP-ribose] polymerase tankyrase-1Homo sapiens (human)1.7564
Poly [ADP-ribose] polymerase 1Homo sapiens (human)0.0278
5-hydroxytryptamine receptor 2ARattus norvegicus (Norway rat)0.0021
Sodium-dependent dopamine transporterRattus norvegicus (Norway rat)0.0021
D(2) dopamine receptorRattus norvegicus (Norway rat)0.0021
Protein mono-ADP-ribosyltransferase PARP14Homo sapiens (human)1.7378
Protein mono-ADP-ribosyltransferase PARP10Homo sapiens (human)2.6153
Protein mono-ADP-ribosyltransferase PARP12Homo sapiens (human)0.4367
Poly [ADP-ribose] polymerase tankyrase-2Homo sapiens (human)5.1293
Poly [ADP-ribose] polymerase 2Homo sapiens (human)0.2306
Protein mono-ADP-ribosyltransferase PARP4Homo sapiens (human)0.4076
Protein mono-ADP-ribosyltransferase PARP3Homo sapiens (human)0.3797

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M1

Other Studies

1 other study(ies) available for n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine and niraparib

ArticleYear
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
    Disease models & mechanisms, 2023, 03-01, Volume: 16, Issue:3

    Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries

2023